France

December 2, 2019December 2, 2019

Abivax’s Phase 2b Trial Testing ABX464 for Ulcerative Colitis Cleared to Add French Sites

News

France’s National Agency for the Safety of Medicine and Health Products (ANSM) has cleared the inclusion of French study sites for Abivax‘s new Phase 2b clinical trial, intended to evaluate ... Read more

September 25, 2017

France Is First EU Country to Give Abivax Go-ahead to Test ABX464 in Ulcerative Colitis

News

France has become the first European country to give Abivax a green light to start clinical trials of ABX464 as a treatment for moderate-to-severe active ulcerative colitis. The therapy candidate is already being tested ... Read more